Speaker illustration

Doctor Adam Ioannou

UCL, Greater London (United Kingdom of Great Britain & Northern Ireland)

Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping

Event: Heart Failure 2023

Topic: Imaging

Session: Cardiac amyloidosis from epidemiology to treatment

Thumbnail

Tracking multi-organ treatment response in systemic AL amyloidosis with cardiac magnetic resonance derived extracellular volume mapping

Event: EACVI 2023

Topic: Myocardial Disease

Session: Young Investigators Award Clinical Cardiology

Thumbnail

Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping

Event: EACVI 2023

Topic: Myocardial Disease

Session: Dechiphering the phenotypes and dynamics of cardiomyopathies under the light of multi-modality imaging

Thumbnail

Automated analysis of echocardiograms at diagnosis is able to predict prognosis in ATTR cardiomyopathy

Event: EACVI 2023

Topic: Myocardial Disease

Session: Cardiac Amyloidosis 1

Thumbnail

Myocardial ischaemia in cardiac amyloidosis: a change of perspective

Event: ESC Congress 2022

Topic: Infiltrative Myocardial Disease

Session: A focus on cardiac amyloidosis

Thumbnail

Multi-imaging characterisation of cardiac phenotype in different types of amyloidosis

Event: ESC Congress 2022

Topic: Infiltrative Myocardial Disease

Session: Cardiac amyloidosis

Thumbnail

Changes in referral pathway and phenotypic status of patients diagnosed with ATTR cardiac amyloidosis during the past 20 years

Event: ESC Congress 2022

Topic: Infiltrative Myocardial Disease

Session: Cardiac amyloidosis: steps ahead

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb